If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
<br /> HEPATOLOGY<br /> EMJ Hepatol. 2018 Suppl 2 • europeanmedical-journal.com<br /> INSIDE<br /> Covered Transjugular<br /> Intrahepatic Portosystemic<br /> Shunt in the Treatment<br /> of Portal Hypertension:<br /> Looking for the Right<br /> Patient and the Right Time<br /> Covered Transjugular Intrahepatic Portosystemic<br /> Shunt in the Treatment of Portal Hypertension:<br /> Looking for the Right Patient and the Right Time<br /> Authors: Marco Senzolo,1 Dominique Thabut,2 *Jonel Trebicka3,4<br /> 1. Multivisceral Transplant Unit, Gastroenterology, Department of Surgical and<br /> Gastroenterological Sciences, University Hospital of Padua, Padua, Italy<br /> 2. Paris Sorbonne Université, AP-HP, Brain-Liver Pitié-Salpêtrière Study<br /> Group (BLIPS), UF de Soins Intensifs d’Hépato-gastroentérologie, Service<br /> D’Hépato-gastroentéterologie, Groupe Hospitalier Pitié-Salpêtrière-Charles Foix,<br /> Paris, France<br /> 3. Depa<a title="EMJ Hepatol. 2018 Suppl 2 page 1" href="http://viewer.zmags.com/publication/9400c5ab?page=1"> HEPATOLOGY EMJ Hepatol. 2018 Suppl 2 • europeanme</a> <a title="EMJ Hepatol. 2018 Suppl 2 page 2" href="http://viewer.zmags.com/publication/9400c5ab?page=2"> Covered Transjugular Intrahepatic Portosystemic </a> <a title="EMJ Hepatol. 2018 Suppl 2 page 3" href="http://viewer.zmags.com/publication/9400c5ab?page=3"> adverse events and increase clinical benefits of T</a> <a title="EMJ Hepatol. 2018 Suppl 2 page 4" href="http://viewer.zmags.com/publication/9400c5ab?page=4"> receive standard therapy, with or without active </a> <a title="EMJ Hepatol. 2018 Suppl 2 page 5" href="http://viewer.zmags.com/publication/9400c5ab?page=5"> CLINICAL EFFECTS OF TRANSJUGULAR INTRAHEPATIC POR</a> <a title="EMJ Hepatol. 2018 Suppl 2 page 6" href="http://viewer.zmags.com/publication/9400c5ab?page=6"> to respond to diuretics should also b</a> <a title="EMJ Hepatol. 2018 Suppl 2 page 7" href="http://viewer.zmags.com/publication/9400c5ab?page=7"> 1.0 TIPS group 93%; 95% CI [82–100%] 0.8 p=0.003 </a> <a title="EMJ Hepatol. 2018 Suppl 2 page 8" href="http://viewer.zmags.com/publication/9400c5ab?page=8"> it as an indication are limited. TIPS can also re</a> <a title="EMJ Hepatol. 2018 Suppl 2 page 9" href="http://viewer.zmags.com/publication/9400c5ab?page=9"> Table 1: Key patient groups with complications of</a> <a title="EMJ Hepatol. 2018 Suppl 2 page 10" href="http://viewer.zmags.com/publication/9400c5ab?page=10"> conference on TIPS management: 26. Tech</a> <a title="EMJ Hepatol. 2018 Suppl 2 page 11" href="http://viewer.zmags.com/publication/9400c5ab?page=11"> the Study of the Liver. Hepatology. 55. 2</a>